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Stress is a major factor that promotes tobacco use and relapse during withdrawal. Although
women are more vulnerable to tobacco use than men, the manner in which stress con-
tributes to tobacco use in women versus men is unclear.Thus, the goal of this study was to
compare behavioral and biological indices of stress in male and female rats during nicotine
withdrawal. Since the effects of nicotine withdrawal are age-dependent, this study also
included adolescent rats. An initial study was conducted to provide comparable nicotine
doses across age and sex during nicotine exposure and withdrawal. Rats received sham
surgery or an osmotic pump that delivered nicotine. After 14 days of nicotine, the pumps
were removed and controls received a sham surgery. Twenty-four hours later, anxiety-like
behavior and plasma corticosterone were assessed.The nucleus accumbens (NAcc), amyg-
dala, and hypothalamus were examined for changes in corticotropin-releasing factor (CRF)
gene expression. In order to differentiate the effects of nicotine withdrawal from expo-
sure to nicotine, a cohort of rats did not have their pumps removed. The major finding is
that during nicotine withdrawal, adult females display higher levels of anxiety-like behavior,
plasma corticosterone, and CRF mRNA expression in the NAcc relative to adult males.
However, during nicotine exposure, adult males exhibited higher levels of corticosterone
and CRF mRNA in the amygdala relative to females. Adolescents displayed less nicotine
withdrawal than adults. Moreover, adolescent males displayed an increase in anxiety-like
behavior and an up-regulation of CRF mRNA in the amygdala during nicotine exposure
and withdrawal. These findings are likely related to stress produced by the high doses of
nicotine that were administered to adolescents to produce equivalent levels of cotinine
as adults. In conclusion, these findings suggest that intense stress produced by nicotine
withdrawal may contribute to tobacco use in women.
Keywords: sex difference, adolescent, adolescence, CRF, nucleus accumbens, tobacco
INTRODUCTION
Epidemiological reports have indicated that women are more
susceptible to tobacco use as compared to men (Perkins, 2009;
Lombardi et al., 2011; Rahmanian et al., 2011). For example,
women consume more tobacco products relative to men (Ham-
mond, 2009; Oh et al., 2010). Women also exhibit higher relapse
rates and are less likely to benefit from nicotine replacement ther-
apy (NRT) than men (Perkins, 2001; Cepeda-Benito et al., 2004;
Schnoll et al., 2007; Perkins and Scott, 2008; Piper et al., 2010).
During abstinence from tobacco, women also report more intense
symptoms of withdrawal than men (Heishman et al., 2010; Naka-
jima and al’Absi, 2012; Perkins et al., 2013). There is also evidence
to suggest that the enhanced susceptibility to tobacco use in women
begins at a young age. For example,a recent survey revealed that the
daily consumption of tobacco is higher in adolescent females than
males [Centers for Disease Control and Prevention (CDC), 2012].
During abstinence from tobacco, adolescent females also report
higher levels of stress and relapse rates as compared to adolescent
males (Anderson and Burns, 2000; Colby et al., 2000; Dickmann
et al., 2009). Regardless of age, females are at a higher risk of devel-
oping tobacco-related diseases than males (Langhammer et al.,
2000, 2003; Kiyohara and Ohno, 2010). Despite the magnitude of
this problem, there is a critical knowledge gap regarding the factors
that contribute to enhanced vulnerability to tobacco use among
women.
Stress has emerged as a major factor that contributes to tobacco
use in women. For example, women report more often than men
that the anxiety-reducing effects of cigarettes are the main reason
for smoking (Perkins and Scott, 2008; Piper et al., 2010; Perkins
et al., 2012). Although tobacco is used to cope with anxiety, long-
term tobacco use is also motivated by avoiding negative affective
states, such as stress, that emerge during withdrawal (Aronson
et al., 2008; Hughes and Callas, 2010; Parrott and Murphy, 2012;
Perkins et al., 2012). Accordingly, women also report higher levels
of stress during abstinence from tobacco than men (Schnoll et al.,
2007; Perkins and Scott, 2008; Xu et al., 2008; Perkins et al., 2012;
Saladin et al., 2012). In addition, women display higher levels of
cortisol (a biological marker of stress in humans) during tobacco
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abstinence as compared to men (Hogle and Curtin, 2006). These
studies suggest that stress is an important factor that contributes
to tobacco use in women.
Pre-clinical evidence has established that the motivational
properties of tobacco are due, in large part, to the presence of nico-
tine. A study comparing sex differences during withdrawal from
nicotine demonstrated that female adult rats display more physi-
cal signs of nicotine withdrawal relative to males (Hamilton et al.,
2009). Also, female adult mice display more anxiety-like behavior
on the elevated plus maze during nicotine withdrawal as compared
to males (Caldarone et al., 2008). Taken together, there is evidence
at the clinical and pre-clinical levels to suggest that females experi-
ence higher levels of stress during nicotine withdrawal. However,
there are several remaining questions with regard to the under-
lying neurobiology that modulates the contribution of stress to
tobacco use in females.
The main neuroendocrine substrate of the stress response is
the hypothalamic-pituitary-adrenal (HPA) axis (see Smith and
Vale, 2006; Gallagher et al., 2008). When a stressor is experi-
enced, corticotropin-releasing factor (CRF) is secreted from the
hypothalamus that then stimulates adrenocorticotropic hormone
(ACTH) release from the pituitary gland. ACTH then simulates
the release of corticosterone and other glucocorticoids from the
adrenal cortex. Corticosterone serves as a major negative feed-
back that terminates HPA axis activity. Within the hypothalamus,
corticosterone binds to nuclear glucocorticoid receptor II sub-
units causing an inhibition of CRF mRNA synthesis. Studies
comparing biological indices of stress produced by nicotine with-
drawal have demonstrated that plasma levels of corticosterone
and ACTH are increased in rats experiencing withdrawal from
this drug (Rhodes et al., 2004; Semba et al., 2004; Lutfy et al.,
2006). With regard to sex differences, female adult rats display ele-
vated plasma levels of corticosterone and ACTH during nicotine
withdrawal relative to males (Gentile et al., 2011; Skwara et al.,
2012).
Recent theories of drug abuse have suggested that CRF plays
a central role in the development of negative affective states that
emerge during withdrawal (Koob and Volkow, 2010). Changes
in CRF systems are hypothesized to occur within brain struc-
tures of the extended amygdala, including the central nucleus of
the amygdala, and the nucleus accumbens (NAcc) (Koob, 2010;
Bruijnzeel, 2012). Pre-clinical work with nicotine has supported
this hypothesis, as CRF-like immunoreactivity is increased in
the amygdala during nicotine withdrawal (George et al., 2007).
Consistent with this, CRF mRNA levels are over-expressed in
the central nucleus of the amygdala during nicotine withdrawal
(Aydin et al., 2011). Also, administration of non-specific CRF-
R1/R2 receptor antagonists into the amygdala or NAcc have been
shown to reverse the deficits in brain reward function produced by
nicotine withdrawal (Marcinkiewcz et al., 2009; Bruijnzeel et al.,
2012). Collectively, these studies suggest that CRF systems within
the NAcc and amygdala play an important role in mediating nico-
tine withdrawal. To our knowledge; however, no one has examined
whether the influence of CRF systems on nicotine withdrawal is
sex-dependent.
Thus, the goal of this study was to compare various biologi-
cal and behavioral indices of stress during nicotine withdrawal in
female and male rats. Anxiety-like behavior was examined on the
elevated plus maze and open-field tests. Plasma corticosterone lev-
els, and changes in CRF gene expression in the amygdala and NAcc
were also explored. CRF gene expression was also examined in the
hypothalamus given the primary role of this structure in initiating
stress responses. A sub-goal of this study was to examine whether
sex differences in adult rats occur during the adolescent period
of development. Thus, the biological and behavioral indices of
stress produced nicotine withdrawal were also compared in ado-
lescent male and female rats. In order to differentiate the effects of
withdrawal from those produced by nicotine exposure, a separate
cohort of rats from both age and sex groups did not experience
withdrawal and were assessed with nicotine circulating in their
system. Another important factor to consider when comparing
the effects of nicotine across age and sex is differences in metab-
olism of this drug. Given this potential confound, an initial study
was conducted to determine equivalent plasma levels of nicotine
in female and male rats of both ages.
MATERIALS AND METHODS
ANIMALS
Male and female adult (n= 92) and adolescent (n= 98) Wistar rats
were used. Rats were bred in the Psychology Department from a
stock of out bred Wistar rats from Harlan, Inc. (Indianapolis, IN,
USA). All rats were housed in groups of two to three per cage
in a humidity- and temperature-controlled (20–22˚C) vivarium
using a 12-/12-hour light/dark cycle with lights off at 8:00 a.m.
The home cages consisted of a rectangular Plexiglas® hanging
cage (41.5 cm long× 17 cm wide× 21 cm high) with pine bed-
ding. Rats had ad libitum access to standard rodent chow and water
at all times except during testing. Adults were postnatal day (PND)
60 and adolescents were PND 28 at the start of the experiment. All
rats were handled for approximately 5 min/day for 3 days prior to
the start of experimentation. All procedures were approved by the
UTEP Animal Care and Use Committee and followed the guide-
lines of the National Institutes of Health Guide for the Care and
Use of Laboratory Animals.
NICOTINE EXPOSURE ANDWITHDRAWAL
Rats were anesthetized with an isoflurane/oxygen mixture (1–
3% isoflurane) and received a sham surgery or were surgically
prepared with subcutaneous pumps that delivered nicotine con-
tinuously for 14 days. After 14 days of nicotine exposure, the
pumps were surgically removed and control rats received another
sham surgery. After pump removal, rats were returned to their
home cages. Twenty-four hours later, rats were tested for various
behavioral and biological measures of anxiety.
STUDY 1: ASSESSING NICOTINE METABOLISM ACROSS
EXPERIMENTAL CONDITIONS
Nicotine metabolism was assessed indirectly by comparing coti-
nine levels in plasma from adolescent and adult male and female
rats during exposure and withdrawal from nicotine. Adult rats
received pumps that were appropriately sized for larger ani-
mals (4.5 mm in length; Alzet model 2ml2), whereas adolescents
received either one or two pumps that were approximately half
as small (2.5 mm in length; Alzet model 2002). Different doses
Frontiers in Psychiatry | Addictive Disorders and Behavioral Dyscontrol May 2013 | Volume 4 | Article 38 | 2
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Torres et al. Females display stress during withdrawal
of nicotine were delivered for 14 days, as described below. Plasma
samples were collected from tail blood on days 7, 10, and 14 of
nicotine exposure. After 14 days of nicotine exposure, the pumps
were surgically removed and plasma samples were collected 6, 12,
and 24 h later.
Separate groups of rats were used to determine equivalent
doses in adolescent and adult male and female rats. One group of
male and female adults was prepared with pumps (model 2ml2)
that delivered a nicotine dose of 3.2 mg/kg/day (expressed as base
form) that produces robust physical and affective signs of with-
drawal in adult rats (O’Dell et al., 2004). Given the fast growth
rates and drug metabolism during adolescence, three groups of
adolescent rats received pumps with different nicotine doses and
experimental procedures. First, a group of male and female ado-
lescents was prepared with one small pump (model 2002) that
delivered 4.7 mg/kg/day of nicotine for 14 days. This dose was
selected from previous work showing that adolescents implanted
with a large pump (model 2ml2) require 1.5-fold higher doses of
nicotine to produce equivalent levels in adult rats (O’Dell et al.,
2006). Second, a group of male and female adolescents was pre-
pared with one small osmotic pump containing 4.7 mg/kg/day
of nicotine. Seven days later, the pump was replaced with a new
pump that was re-adjusted for the rats’ rapid weight gain. Last, a
third group of male and female adolescents was prepared with two
small pumps that each delivered 4.7 mg/kg/day each of nicotine for
14 days. This group received a total of 9.4 mg/kg/day of nicotine.
Plasma cotinine levels were analyzed using commercially available
96-well plate ELISA kits (OraSure Technologies, Inc., Bethlehem,
PA, USA). Standard curves were used to estimate plasma coti-
nine levels using a Spectra Maxplus spectrophotometer (Molecular
Devices Inc., Sunnyvale, CA, USA).
STUDY 2: ASSESSING BEHAVIORAL AND BIOLOGICAL INDICES OF
STRESS DURING NICOTINE EXPOSURE ANDWITHDRAWAL
Adolescent and adult male and female rats received a sham surgery
or were implanted with nicotine pumps (Alzet model 2ml2 for
adults and two Alzet models 2002 for adolescents). Adult rats
received a nicotine dose of 3.2 mg/kg/day (expressed as base form)
for 14 days and adolescent rats received a total nicotine dose of
9.4 mg/kg/day (expressed as base form) for 14 days. To minimize
stress produced by repeated tail vein blood sampling from study
1, separate groups of rats were used in this study.
After 14 days of nicotine exposure, the pumps were removed to
induce spontaneous withdrawal. Twenty-four hours after pump
removal, behavioral tests were conducted to compare physical
signs of withdrawal and anxiety-like behavior, using the elevated
plus maze and open-field tests. After behavioral testing, the brains
were removed and analyzed for CRF mRNA levels using qRT-PCR.
Blood samples were also collected and analyzed for corticosterone
levels. To examine anxiety-like behavior and biological markers of
stress during nicotine exposure, separate cohorts of rats did not
have their pumps removed and were tested with nicotine circu-
lating in their system on the 14th day of nicotine exposure. At
the time of testing, adult rats were PND 75 and adolescent rats
were PND 43.
Rats were tested for anxiety-like behavior using the elevated
plus maze procedure. The animals were first acclimated to the
testing room in a rectangular Plexiglas® cage for 20 min. After
20 min, the rats were placed onto the elevated plus maze, which
was in the middle of the testing room beneath a red light. The
plus maze apparatus consisted of four arms (10 cm× 50 cm) that
were elevated to a height of 50 cm above the ground. The closed
arms had 40 cm high walls around them, and the open arms did
not have walls that enclosed the open platforms. At the beginning
of the test, the rats were placed into the maze facing the open
arm and time spent in each arm was recorded for 5 min. The maze
was thoroughly cleaned with 70% ethanol and then water between
each individual test. Rats that fell off the maze were excluded from
the study.
After elevated plus maze testing, the rats were returned to the
isolation cage for 10 min. The open-field apparatus consisted of a
clear Plexiglas® box (60 cm× 60 cm× 15 cm) that was positioned
in the middle of an adjacent room beneath a red light. The walls
of the maze were clear and the floor was divided into 25 equal
squares (12 cm× 12 cm; 16 peripheral and 9 center squares). At
the start of the test, rats were placed in the center of the open field,
and time spent in the center versus corner areas was recorded
for 5 min.
After the open-field test, the rats were returned to the isolation
cage for somatic signs of withdrawal testing. Ten minutes later, the
rats were moved to another testing room and placed in a clear Plex-
iglas® cylindrical container (30 cm× 29 cm) cage for 10 min. Rats
were then monitored for physical signs of nicotine withdrawal for
10 min. The observed signs include blinks, writhes, body shakes,
teeth chatters, gasps, and ptosis. If present, ptosis was counted only
once. The total number of somatic signs was defined as the sum
of individual occurrences of the aforementioned signs during the
entire observation period. The duration of the entire test battery
was approximately 70 min.
After behavioral testing, rats were sacrificed by rapid decapi-
tation to ensure preservation of the neurochemical environment
and minimize degradation during tissue dissection. The amygdala,
hypothalamus, and NAcc from both hemispheres were collected
and flash frozen at −80˚C within an estimated time of 30 s from
sacrifice. Total RNA was isolated from neuronal tissue samples
using the All Prep DNA/RNA Mini kit (QIAGEN, Inc.) for small
tissue sections. After isolation, RNA was quantified using a UV/V
spectrophotometer (Beckman Coulter Inc.). The target ratio of
1.8–2.0 for A260/280 was used as an inclusion criterion for all
RNA samples. The quality of the RNA was then visualized by
MOPS 1% agarose gel (37% formaldehyde) using the Thermo
Scientific easy cast electrophoresis system. The gels were verified
for characteristic 18S and 28S ribosomal RNA bands using ethid-
ium bromide and the Bio-Rad ChemiDoc XRS+ imaging system.
Samples that had insufficient amounts of RNA were excluded from
further analyses. One microgram of total RNA was then digested
with DNaseI, Amp Grade (Invitrogen) prior to cDNA synthesis
in order to remove any DNA contamination. The RNA was then
reverse transcribed into cDNA with the Advantage® RT-for-PCR
kit (Clontech) using Oligo(dT) primers, following the manufac-
turer’s instructions. Once the cDNA was synthesized, the cDNA
samples were diluted 1:10 in nuclease-free water, separated into
aliquots and stored at−20˚C. Specific primers for CRF and refer-
ence gene ribosomal protein L13A (RPL13A) were obtained from
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Table 1 | Primer sequences.
Symbol Forward primer Reverse primer
CRF 5′ ATGCTGCTGGTGGCTCTGT 3′ 5′ GGATCAGAATCGGCTGAGGT 3′
RPL13A 5′ GGATCCCTCCACCCTATGACA 3′ 5′ CTGGTACTTCCACCCGACCTC 3′
GAPDH 5′ CAACTCCCTCAAGATTGTCAGCAA 3′ 5′ GGCATGGACTGTGGTCATGA 3′
Pol2a 5′ CGTATCCGCATCATGAACAGTGA 3′ 5′ TCATCCATCTTATCCACCACCTCTT 3′
Actb 5′ CTATGAGCTGCCTGACGGTC 3′ 5′ AGTTTCATGGATGCCACAGG 3′
Integrated DNA Technologies, Inc., with amplicons between 71
and 142 base-pairs (see Table 1).
The rationale for using RPL13A as a reference gene is based
upon an initial study examining tissue from a group of adult rats
(n= 27) that was conducted before quantifying CRF gene expres-
sion across experimental groups. Four commonly used reference
genes were tested as potential candidates for the normalizing gene,
including: actin (Actb), glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH), RNA polymerase II (Pol2a), and RPL13A. The
findings revealed that the expression of RPL13A was the most
stable and similar across male and female control and nicotine-
treated rats. Based on our results, we believe that expression profil-
ing of normalizing genes is important when employing qRT-PCR
techniques involving male and female rats.
Commercially available SYBR® Fast qPCR fluorescent label-
ing kits (Kapa Biosystems, Inc.) were used to perform qRT-PCR
using the Mastercycler ep Realplex2 System (Eppendorf, Inc.).
All samples were analyzed in triplicates and amplified by the
following protocol: initial denaturing at 95˚C for 5 min, con-
tinued denaturing at 95˚C for 15 s; annealing at 59˚C for 15 s;
extension at 68˚C for 20 s, for a total of 40 cycles. CRF mRNA
expression was normalized by RPl-13A mRNA expression using
the comparative CT method adopted from Schmittgen and Livak
(2008). The amplification specificity for each primer was tested
for a single-product, as shown by a single band via TAE 1% gel
electrophoresis and visualized on the Bio-Rad ChemiDoc XRS+
system.
Corticosterone levels were assessed in blood samples that were
collected from trunk blood during sacrifice. The samples were cen-
trifuged for 15 min at 5,000× g at 4˚C. The resultant plasma was
then stored at −80˚C until analyzed. Corticosterone levels were
estimated using a 96-well plate ELISA kit (Assaypro Inc.) using a
Spectra Maxplus spectrophotometer (Molecular Devices Inc.).
STATISTICAL APPROACH
For study 1, cotinine values during nicotine exposure were ana-
lyzed using a three-factor mixed model ANOVA with sex (male
and female), and age (adult and adolescent) as between subject
factors, and day of sampling (7, 10, and 14 days) as a repeated
measures factor. Similarly, cotinine values during nicotine with-
drawal were analyzed using a three-factor mixed model ANOVA
with sex (male and female), and age (adult and adolescent) as
between subject factors, and time of sampling (6, 12, and 24 h)
as a repeated measures factor. For study 2, each measure was
analyzed separately using three-factor ANOVAs with sex (male
and female), age (adult and adolescent), and treatment (control,
nicotine exposure, and nicotine withdrawal) as between subject
factors. In cases where three-way interaction effects were signif-
icant, individual group comparisons were reported. However, in
cases where three-way interactions were not significant, two-way
interactions were reported. All post hoc tests were conducted using
Fisher’s LSD tests where appropriate (P< 0.05). Given that the
results revealed interaction effects, main effects were not reported.
Thus, interaction effects were reported with post hoc tests, and
main effects were not included given the interaction effects pro-
vide more information about group differences, which was the
goal of the paper.
RESULTS
Figure 1 illustrates cotinine levels across adolescent and adult
male and female rats during nicotine exposure and withdrawal.
Regarding sex differences, the results revealed that there were no
sex differences in cotinine levels during nicotine exposure [F(1,
79)= 0.96, P> 0.05] and withdrawal [F(1, 84)= 0.19, P> 0.05]
regardless of the age of the animals. This suggests that sex dif-
ferences can be appropriately compared across all of the nicotine
pump conditions. Regarding age differences during nicotine expo-
sure, adults displayed higher cotinine levels than adolescents pre-
pared with one small pump and adolescents re-implanted with
one small pump that was adjusted for weight gain (main effect
of treatment) [F(3, 79)= 8.96, P< 0.05]. However, adult cotinine
levels were similar to that of adolescents prepared with two small
pumps that each delivered 4.7 mg/kg/day of nicotine for 14 days. A
similar pattern was observed during nicotine withdrawal, such that
similar levels of cotinine were observed in adults and adolescents
that were implanted with two small pumps that each delivered a
nicotine dose of 4.7 mg/kg/day. These data suggest that adolescents
require two osmotic pumps delivering a total nicotine volume of
9.4 mg/kg/day to produce similar cotinine levels as adults with one
pump that delivers 3.2 mg/kg/day.
Table 2 denotes total somatic signs of withdrawal
(mean± SEM) during nicotine exposure and withdrawal in adult
and adolescent male and female rats. Somatic signs were analyzed
using the total amount of signs elicited during the entire obser-
vation period. A three-way analysis of withdrawal signs revealed
that there were no interaction effects between sex, age, and treat-
ment [F(2, 92)= 0.84, P> 0.05]. However, a two-way analysis of
withdrawal signs revealed a significant interaction between age
and treatment [F(2, 92)= 12.08, P< 0.05]. Subsequent post hoc
analyses revealed that adult rats that were tested during nicotine
withdrawal displayed an increase in signs of withdrawal compared
to their respective controls (∗P< 0.05). There were no differences
in the magnitude of withdrawal signs across male and female
adolescent rats.
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FIGURE 1 | Blood plasma cotinine levels (ng/ml±SEM) 7, 10, and
14 days during nicotine exposure (top row) and then 6, 12, and 24 h
after pump removal (bottom row) in adult and adolescent male and
female rats. Adult rats (n=26) received a large pump (model 2ml2) that
delivered nicotine 3.2 mg/kg for 14 days. Three separate groups of
adolescent rats received a smaller model of pump (model 2002) that
delivered: (1) a dose of 4.7 mg/kg/day for 14 days (n=17), (2) a dose of
4.7 mg/kg/day that was replaced after 7 days with a new pump that also
delivered 4.7 mg/kg/day (n=17), and (3) a dose of 9.4 mg/kg/day that was
divided in two small pumps (n=32). The dagger (†) denotes a significant
difference across all time points between nicotine-treated adolescents and
adults (P <0.05).
Figure 2 illustrates anxiety-like behavior as assessed by the
elevated plus maze during nicotine exposure and withdrawal.
Anxiety-like behavior was operationally defined as an increase in
time spent in the closed arm as compared to controls. A three-way
analysis of percent time spent in the closed arm revealed a signifi-
cant interaction between sex, age, and treatment [F(2, 96)= 8.85,
P< 0.05]. Subsequent post hoc analyses revealed that adult females
that were tested during nicotine exposure displayed an increase
in anxiety-like behavior relative to controls (∗P< 0.05). How-
ever, adult females tested during nicotine withdrawal displayed
an increase in anxiety-like behavior that was significantly higher
than their respective controls (∗P< 0.05), male counterparts
(†P< 0.05), and adolescent counterparts (#P< 0.05). In adoles-
cents, the males displayed the largest effects of nicotine exposure
and withdrawal on anxiety-like behavior as compared to respec-
tive controls (∗P< 0.05), female counterparts (†P< 0.05), and
adolescent counterparts (#P< 0.05).
Figure 3 illustrates anxiety-like behavior as assessed by the
open-field test during nicotine exposure and withdrawal. Anxiety-
like behavior was operationally defined as an increase in time spent
in the corners of the open field as compared to controls. A three-
way analysis of percent corner time revealed a significant interac-
tion between sex, age, and treatment [F(2, 92)= 3.85, P< 0.05].
Subsequent post hoc analyses revealed that adult females tested
during nicotine exposure displayed an increase in anxiety-like
behavior relative to controls (∗P< 0.05). However, adult females
tested during nicotine withdrawal displayed an increase in anxiety-
like behavior that was higher than respective controls (∗P< 0.05)
Table 2 | Physical signs of withdrawal.
Experimental
group
Adult
male
Adult
female
Adolescent
male
Adolescent
female
Controls 7.6±0.8 7.8±0.9 5±0.7 3.8±0.3
Nicotine exposure 5.2±0.4 4.3±0.3 3.2±0.3 4.3±0.5
Nicotine withdrawal *15.5±1.8 *11.5±1.4 3.8±0.3 3.2±0.6
The asterisks (*) denote a significant difference from respective controls
(P<0.05).
and their male counterparts (†P< 0.05). In adolescents, males
tested during nicotine withdrawal displayed an increase in anxiety-
like behavior relative to controls (∗P< 0.05). Adolescent female
controls displayed an increase in anxiety-like behavior relative to
males (†P< 0.05) and their adult counterparts (#P< 0.05).
Figure 4 illustrates plasma corticosterone levels during nico-
tine exposure and withdrawal. A three-way analysis of corticos-
terone levels revealed a significant interaction between sex, age,
and treatment [F(2, 66)= 3.2, P< 0.05]. Subsequent post hoc
analyses revealed that adult males tested during nicotine expo-
sure displayed an increase in corticosterone levels relative to
controls (∗P< 0.05). Adult females tested during nicotine with-
drawal displayed an increase in corticosterone levels relative to
controls (∗P< 0.05), male counterparts (†P< 0.05), and ado-
lescent counterparts (#P< 0.05). In adolescents, the male con-
trols and males tested during nicotine withdrawal displayed an
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FIGURE 2 | Percent time spent in the closed arm of the elevated plus
maze during nicotine exposure and withdrawal in adult male
(control n=13; nicotine exposure n=15; nicotine withdrawal n=9),
adult female (control n=10; nicotine exposure n=16; nicotine
withdrawal n=13), adolescent male (control n=6; nicotine
exposure n=5; nicotine withdrawal n=5), and adolescent female
(control n= 6; nicotine exposure n=5; nicotine withdrawal n=5)
rats. The asterisks (*) denote a significant difference between
nicotine-treated rats and their respective controls, the daggers (†) denote
a significant difference between males and females, and the number
signs (#) denote a significant difference between adults and adolescents
(P<0.05).
FIGURE 3 | Percent time spent in the corner areas in the open-field
testing during nicotine exposure and withdrawal in adult male
(control n=9; nicotine exposure n=15; nicotine withdrawal
n=10), adult female (control n=10; nicotine exposure n=16;
nicotine withdrawal n=13), adolescent male (control n=6;
nicotine exposure n=5; nicotine withdrawal n= 5), and
adolescent female (control n= 5; nicotine exposure n=5; nicotine
withdrawal n=5) rats. The asterisks (*) denote a significant
difference between nicotine-treated rats and their respective controls,
the daggers (†) denote a significant difference between males and
females, and the number sign (#) denotes a significant difference
between adults and adolescents (P< 0.05).
increase in corticosterone levels relative to their adult counterparts
(#P< 0.05).
Figure 5 illustrates CRF gene expression in the NAcc during
nicotine exposure and withdrawal. A three-way analysis of CRF
gene expression revealed a significant interaction between sex, age,
and treatment in this brain region [F(2, 42)= 4.34,P< 0.05]. Sub-
sequent post hoc analyses revealed that adult females tested during
nicotine withdrawal displayed an increase in CRF gene expression
relative to controls (∗P< 0.05), male counterparts (†P< 0.05),
and adolescent counterparts (#P< 0.05). In adolescents, females
tested during nicotine withdrawal displayed a decrease in CRF
gene expression relative to controls (∗P< 0.05).
Figure 6 illustrates CRF gene expression in the amygdala
during nicotine exposure and withdrawal. A three-way analysis
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FIGURE 4 | Plasma corticosterone levels during nicotine exposure and
withdrawal in adult male (control n=7; nicotine exposure n=9; nicotine
withdrawal n=6), adult female (control n=8; nicotine exposure n=8;
nicotine withdrawal n= 8), adolescent male (control n=6; nicotine
exposure n=5; nicotine withdrawal n= 5), and adolescent female
(control n=6; nicotine exposure n=5; nicotine withdrawal n=5) rats.
The asterisks (*) denote a significant difference between nicotine-treated male
and female adult rats and their respective controls, the dagger (†) denotes a
significant difference between males and females, and the number signs (#)
denote a significant difference between adolescents and adults (P<0.05).
FIGURE 5 | CRF gene expression in the NAcc during nicotine exposure
and withdrawal in adult male (control n=4; nicotine exposure n=4;
nicotine withdrawal n=4), adult female (control n=4; nicotine exposure
n=4; nicotine withdrawal n=4), adolescent male (control n=6; nicotine
exposure n=5; nicotine withdrawal n= 5), and adolescent female
(control n=5; nicotine exposure n=4; nicotine withdrawal n=5) rats.
The asterisks (*) denote a significant difference between nicotine-treated rats
and their respective female controls, the dagger (†) denotes a significant
difference between male and female rats, and the number sign (#) denotes a
significant difference between adolescent and adult rats (P < 0.05).
of CRF gene expression revealed that there were no inter-
action effects between sex, age, and treatment in this brain
region [F(2, 52)= 0.21, P > 0.05]. However, a two-way analy-
sis of CRF gene expression in the amygdala revealed a signif-
icant interaction between sex and treatment [F(2, 52)= 3.72,
P< 0.05]. Subsequent post hoc analyses revealed that adult and
adolescent male rats tested during nicotine exposure displayed
a significant increase in CRF gene expression as compared to
controls (∗P< 0.05) and female counterparts (†P< 0.05). In
addition, adolescent males tested during nicotine withdrawal
displayed an increase in CRF gene expression relative to controls
(∗P< 0.05).
Figure 7 illustrates CRF gene expression in the hypothalamus
during nicotine exposure and withdrawal. A three-way analysis
of CRF gene expression revealed that there were no interaction
effects between sex, age, and treatment in this brain region [F(2,
68)= 0.02,P > 0.05]. Also, a two-way analysis of CRF gene expres-
sion revealed that there were no interaction effects between sex and
treatment [F(2, 68)= 1.27, P > 0.05] or age and treatment [F(2,
68)= 0.41, P > 0.05].
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FIGURE 6 | CRF gene expression in the amygdala during nicotine
exposure and withdrawal in adult male (control n=10; nicotine
exposure n=5; nicotine withdrawal n=5), adult female (control n=7;
nicotine exposure n=7; nicotine withdrawal n= 4), adolescent male
(control n= 4; nicotine exposure n=6; nicotine withdrawal n=4), and
adolescent female (control n= 4; nicotine exposure n=4; nicotine
withdrawal n=4) rats. The asterisks (*) denote a significant difference
between nicotine-treated rats and their respective male controls (P<0.05).
FIGURE 7 | CRF gene expression in the hypothalamus during
nicotine exposure and withdrawal in adult male (control n=13;
nicotine exposure n=13; nicotine withdrawal n=6), adult
female (control n=6; nicotine exposure n=6; nicotine
withdrawal n=4), adolescent male (control n=8; nicotine
exposure n=5; nicotine withdrawal n=5), and adolescent
female (control n=5; nicotine exposure n=5; nicotine
withdrawal n=6) rats.
DISCUSSION
To summarize, during nicotine withdrawal, adult females dis-
played increases in anxiety-like behavior, increases in plasma cor-
ticosterone levels, and changes in CRF gene expression in the NAcc
that were higher as compared to males. Control studies comparing
sex differences during nicotine exposure, revealed that adult males
displayed an increase in plasma corticosterone levels and increases
in CRF gene expression in the amygdala. The sex differences in
adults did not appear to be confounded by nicotine metabo-
lism, since cotinine values were the same in male and female rats
throughout our experimental procedures. Regarding age differ-
ences, adolescent males displayed some indices of stress during
nicotine exposure that persisted into the withdrawal period. This
may have been related to the high doses of nicotine that the
adolescents required to produce comparable cotinine values as
adults.
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The major finding of this study is that adult females expe-
rience greater behavioral and biological indices of stress during
nicotine withdrawal as compared to males. Adult females spent
more time on the closed arm of the elevated plus maze during
nicotine withdrawal as compared to males. Consistent with this,
adult females also spent more time in the corner areas of the open
field during nicotine withdrawal relative to males. Our behav-
ioral results corroborate with our biological assessment of stress,
as adult females also displayed increases in plasma corticosterone
levels during nicotine withdrawal that were higher than males.
Our results are consistent with previous reports demonstrating
that female adult mice display more anxiety-like behavior on the
elevated plus maze during nicotine withdrawal as compared to
males (Kota et al., 2007, 2008; Caldarone et al., 2008). Two recent
reports also showed that adult female rats display higher plasma
corticosterone levels during nicotine withdrawal as compared to
males (Gentile et al., 2011; Skwara et al., 2012).
The present study also revealed that adult females displayed an
increase in CRF mRNA expression in the NAcc during nicotine
withdrawal that was higher than males. Previous reports support
the role of the NAcc in modulating stress. For example, intra-NAcc
administration of CRF has been shown to produce anxiety-like
behavior on the elevated plus maze (Chen et al., 2012). The NAcc
is also strongly activated following presentation of a stressful stim-
ulus (Noh et al., 2012). The latter report showed that the NAcc was
activated to a greater extent following restraint stress as compared
to cold-water submersion. Thus, the NAcc may be differentially
responsive to various types of stressors. Our findings suggest that
the NAcc is also involved in stress produced by nicotine with-
drawal. Consistent with this hypothesis, the deficits in brain reward
function produced by nicotine withdrawal are alleviated by block-
ade of CRF receptors in the NAcc (Marcinkiewcz et al., 2009). Our
finding that the hypothalamus was not altered during withdrawal,
is consistent with the finding that CRF mRNA was not altered in
the hypothalamus of male rats experiencing spontaneous nicotine
withdrawal (Semba et al., 2004). Thus, the hypothalamus may not
play a central role in modulating negative affective states involving
stress produced by nicotine withdrawal.
Our findings also suggest that the NAcc is a structure involved
in sex-dependent differences to drug withdrawal. This is con-
sistent with previous studies examining withdrawal from other
drugs of abuse. For example, morphine withdrawal produced a
decrease in µ-opioid receptors in the NAcc of female but not male
mice (Diaz et al., 2006). Also, multiple withdrawal periods from
ethanol produced an increase in proteins involved in vesicular
packaging and exocytosis in the NAcc of female but not male
rats (Bell et al., 2006, 2009). Following abstinence from cocaine
self-administration, delta opioid receptors and dopamine phos-
phoproteins are increased to a greater extent in the NAcc of female
versus male rats (Lynch et al., 2007; Ambrose-Lanci et al., 2008).
Taken together with the present findings, there is strong evidence
to suggest that the NAcc modulates sex differences produced by
withdrawal from drugs of abuse.
There are several ways in which females may be more suscep-
tible to stress produced by nicotine withdrawal. There is much
evidence to suggest that CRF systems are enhanced in females ver-
sus males (Bangasser, 2013; Valentino et al., 2013). Females display
hypersecretion of CRF and more CRF-1 receptors in the locus
coeruleus, a brain region that coordinates arousal components of
the stress response (Curtis et al., 2006; Bangasser et al., 2013).
Females also display a higher ratio of CRF-1 receptors to coupling
of G-proteins versus male rats, suggesting that the female CRF sys-
tem has greater intracellular signaling capacity (Bangasser et al.,
2010). The beta-arrestin2 protein is an intracellular protein that
internalizes the CRF-1 receptor into the cell cytoplasm and pre-
vents it from being activated by CRF (Aguilera et al., 2004; Holmes
et al., 2006). Female rats display lower levels of beta-arrestin2 than
male rats, suggesting that females are more responsive to CRF
stimulation due to reduced internalization of the CRF-1 receptor
as compared to males (Bangasser and Valentino, 2012). Females
may also be more susceptible to stress produced by withdrawal via
ovarian hormones. For example, direct activation of estrogen-beta
receptors (ERβ) increase CRF mRNA expression in vitro (Chen
et al., 2008; Lalmansingh and Uht, 2008; Zhu and Zhou, 2008).
Furthermore, the estrogen gene sequence serves as a promoter of
CRF gene transcription (Vamvakopoulos and Chrousos, 1993).
Collectively, these studies suggest that females have a hypersensi-
tive CRF system, and this may contribute to the enhanced stress
produced by nicotine withdrawal in females versus males.
The present study also revealed a robust increase in CRF gene
expression in the amygdala of male rats during nicotine exposure.
A recent report showed that CRF levels were increased in the amyg-
dala of adult male rats experiencing nicotine withdrawal (George
et al., 2007). The rats in the latter study received a nicotine antag-
onist to precipitate withdrawal while nicotine was being delivered
via an osmotic pump. The findings from the present study are con-
sistent with those of George et al. (2007), given that the rats from
both studies had circulating levels of nicotine in their system at the
time of analysis. Thus, the possibility exists that nicotine directly
activates CRF systems in the amygdala, especially given that the
changes in CRF were not observed in the absence of nicotine in
our study. Future studies are needed to fully understand the role
of CRF systems in the amygdala in modulating the direct effects
of nicotine and the long-term consequences of withdrawal from
this drug. A unique challenge for this work is that nicotine expo-
sure is an inherent part of studies that assess withdrawal, either by
spontaneous or precipitated methods.
The present study also compared sex differences in the somatic
signs of nicotine withdrawal. Our findings suggest that there were
no differences in somatic signs of withdrawal between adult male
and female rats. A report by Hamilton et al. (2009) showed that
female rats display more somatic signs of withdrawal relative to
males. The discrepancy between these reports may be related to
differences in lighting conditions given that Hamilton et al. only
reported sex differences in rats that were tested in dim, but not
well-lit conditions. In the present study, the somatic signs data were
collected in well-lit conditions whereas the anxiety-like behav-
ior was collected in the dark under a red light. Perhaps different
lighting conditions may be considered in future studies examining
anxiety-like behavior produced by nicotine withdrawal, especially
given the reported effects of lighting conditions on the somatic
signs of withdrawal.
Another finding of this study is that male and female ado-
lescents generally displayed fewer somatic signs of withdrawal
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as compared to adults. These findings are consistent with pre-
vious work in our laboratory and others demonstrating that the
behavioral and neurochemical effects of withdrawal are dimin-
ished in adolescent versus adult rats (Smith et al., 2006; Wilmouth
and Spear, 2006; Shram et al., 2008; O’Dell, 2009). This study
extends this work by showing that adolescent females are also less
sensitive to nicotine withdrawal as compared to adult females.
An important caveat; however, is that adolescent males displayed
anxiety-like behavior and biological markers of stress during nico-
tine exposure that persisted 24-h later into withdrawal. There are
two possible explanations for this effect. First, adolescent males
may not be impervious to all aspects of withdrawal, which may
induce a stress response that contributes to tobacco use in ado-
lescent males. Second, it is possible that nicotine elicited a stress
response in adolescent males. This explanation is consistent with
the finding that CRF gene expression was increased in the amyg-
dala of adolescent males during nicotine exposure. We suggest
that the ability of nicotine to induce a stress response was likely
related to the three-fold higher doses of this drug that were used
to produce equivalent plasma levels of cotinine as adults. The
lack of stress effects in female adolescents was likely related to
high tolerance to the aversive effects of nicotine, an effect that has
been previously demonstrated (Torres et al., 2009). Future stud-
ies are needed to examine sex differences to stress produced by
nicotine withdrawal, perhaps with a model such as nicotine vapor
inhalation that circumvents the dosing issues that arose in the
present study with osmotic pumps. Despite this, the present study
provided important parametric information regarding equivalent
doses of nicotine in adolescent and adult rats using different pump
sizes. Our results raise an important issue for future studies com-
paring developmental differences to nicotine since high doses of
nicotine may produce stress in adolescent males.
There are some limitations in the present study. In some cases,
our behavioral and biochemical measures appear to contradict
each other. For example, in adolescent males, we observed an
increase in anxiety-like behavior in the plus maze but not the
open field. This discrepancy is likely related to the sensitivity of
these measures in assessing anxiety-like behavior. In adult females,
during withdrawal, the pattern of changes was consistent (high
anxiety-like behavior and corticosterone). However, during nico-
tine exposure the pattern of changes was not consistent (high
anxiety-like behavior but no changes in corticosterone). The lack
of changes in corticosterone was likely due to a higher baseline
value in adult females. In adult males, during withdrawal, the pat-
tern of changes was consistent (no anxiety-like behavior and no
changes in corticosterone). However,during nicotine exposure, the
pattern of changes was not consistent (no changes in anxiety-like
behavior and an increase in corticosterone). One might argue that
the changes in corticosterone were aberrant; however, this group
also showed an increase in CRF gene expression in the amyg-
dala. Thus, it may be the case the nicotine exposure is more stress
inducing in adult males as compared to withdrawal from this drug.
In conclusion, our results suggest that during nicotine with-
drawal female rats display behavioral and biological markers of
stress that are enhanced compared to males. These findings con-
tribute to a body of literature showing that female rats display
greater rewarding effects of nicotine as compared to males (Donny
et al., 2000; Klein et al., 2004; Chaudhri et al., 2005; Torres et al.,
2009). Taken together, there is pre-clinical evidence to suggest
that enhanced rewarding effects of nicotine and intense stress
produced by withdrawal both contribute to the greater vulnera-
bility to tobacco use observed in women. In addition, our findings
suggest that the most effective cessation treatments for women
should also alleviate intense stress produced by nicotine with-
drawal. For example, one approach might include CRF antagonists
in combination with other tobacco cessation treatments, such
as NRT or partial nicotinic agonists. Future studies are needed
to understand the complex interactions in the brain that mod-
ulate sex differences to nicotine use. This work is important
toward reducing health disparities related to tobacco use among
women.
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